Tissue-type plasminogen activator as a therapeutic target in stroke

By Gravanis Iordanis   Tsirka Stella E  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 2, 2008-02 ,pp. : 159-170

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of the Protease Domain of Urokinase-Type Plasminogen Activator

By  

Current Pharmaceutical Design, Vol. 8, Iss. 28, 2002-12 ,pp. : 2541-2558

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of combination of a tissue-type plasminogen activator and an endothelin receptor antagonist, FR139317, in the rat cerebral infarction model

By Umemura K.   Ishiye M.   Kosuge K.   Nakashima M.  

European Journal of Pharmacology, Vol. 275, Iss. 1, 1995-02 ,pp. : 17-21

Elsevier

Access to resources Recommend Favorite

Ultrasound-responsive thrombus treatment with zinc-stabilized gelatin nano-complexes of tissue-type plasminogen activator

By Uesugi Yoshiko   Kawata Hiroyuki   Saito Yoshihiko   Tabata Yasuhiko  

Journal of Drug Targeting, Vol. 20, Iss. 3, 2012-04 ,pp. : 224-234

Informa Healthcare

Access to resources Recommend Favorite

Small molecule inhibitors of urokinase-type plasminogen activator

By Rockway Todd W  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 6, 2003-06 ,pp. : 773-786

Informa Healthcare

Access to resources Recommend Favorite